Cytotoxic immune activity reflects a coordinated immune microenvironment and is associated with response to total neoadjuvant therapy in rectal cancer.
{"title":"Cytotoxic immune activity reflects a coordinated immune microenvironment and is associated with response to total neoadjuvant therapy in rectal cancer.","authors":"Erina Haraguchi, Norio Tanaka, Kentaro Sato, Tatsuki Noguchi, Takashi Sakamoto, Shimpei Matsui, Toshiki Mukai, Tomohiro Yamaguchi, Eiji Shinozaki, Senzo Taguchi, Akiko Chino, Manabu Takamatsu, Ippei Fukada, Takayuki Ueno, Tetsuo Noda, Seiichi Mori, Takashi Akiyoshi","doi":"10.1007/s00535-026-02502-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Total neoadjuvant therapy (TNT) has emerged as a promising treatment strategy for locally advanced rectal cancer; however, robust biomarkers predicting treatment response remain lacking. We aimed to identify pretreatment transcriptomic determinants of TNT response, focusing on cytotoxic immune activity and its broader immune context.</p><p><strong>Methods: </strong>We analyzed two independent cohorts of patients with rectal cancer treated with TNT: a laser-capture microdissection (LCM) cohort (n = 154) and a bulk tumor cohort (n = 80). Differential gene expression, gene set enrichment, and immune deconvolution analyses were performed using pretreatment RNA sequencing data. Associations between cytotoxic activity and treatment response were evaluated using multivariable models.</p><p><strong>Results: </strong>Only a limited number of genes were reproducibly associated with response across cohorts. Pathway-level analyses revealed enrichment of immune-related signatures in complete responders in the bulk cohort, whereas no significant enrichment was observed in the LCM cohort. Cytotoxic scores showed a consistent directional association with complete response in both cohorts, although modestly, and did not reach statistical significance in the LCM cohort. Cytotoxic activity was strongly correlated with multiple immune cell populations and signaling pathways, including effector and regulatory components, indicating a coordinated immune microenvironment. Multivariable analyses demonstrated that cytotoxic activity was independently associated with treatment response in the bulk cohort and recurrence-free survival in the LCM cohort.</p><p><strong>Conclusions: </strong>Cytotoxic immune activity represents a biologically relevant but modest determinant of response to TNT in rectal cancer. These findings suggest that treatment sensitivity is shaped by a coordinated immune microenvironment rather than cytotoxic activity alone.</p>","PeriodicalId":16059,"journal":{"name":"Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00535-026-02502-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Total neoadjuvant therapy (TNT) has emerged as a promising treatment strategy for locally advanced rectal cancer; however, robust biomarkers predicting treatment response remain lacking. We aimed to identify pretreatment transcriptomic determinants of TNT response, focusing on cytotoxic immune activity and its broader immune context.
Methods: We analyzed two independent cohorts of patients with rectal cancer treated with TNT: a laser-capture microdissection (LCM) cohort (n = 154) and a bulk tumor cohort (n = 80). Differential gene expression, gene set enrichment, and immune deconvolution analyses were performed using pretreatment RNA sequencing data. Associations between cytotoxic activity and treatment response were evaluated using multivariable models.
Results: Only a limited number of genes were reproducibly associated with response across cohorts. Pathway-level analyses revealed enrichment of immune-related signatures in complete responders in the bulk cohort, whereas no significant enrichment was observed in the LCM cohort. Cytotoxic scores showed a consistent directional association with complete response in both cohorts, although modestly, and did not reach statistical significance in the LCM cohort. Cytotoxic activity was strongly correlated with multiple immune cell populations and signaling pathways, including effector and regulatory components, indicating a coordinated immune microenvironment. Multivariable analyses demonstrated that cytotoxic activity was independently associated with treatment response in the bulk cohort and recurrence-free survival in the LCM cohort.
Conclusions: Cytotoxic immune activity represents a biologically relevant but modest determinant of response to TNT in rectal cancer. These findings suggest that treatment sensitivity is shaped by a coordinated immune microenvironment rather than cytotoxic activity alone.
期刊介绍：
The Journal of Gastroenterology, which is the official publication of the Japanese Society of Gastroenterology, publishes Original Articles (Alimentary Tract/Liver, Pancreas, and Biliary Tract), Review Articles, Letters to the Editors and other articles on all aspects of the field of gastroenterology. Significant contributions relating to basic research, theory, and practice are welcomed. These publications are designed to disseminate knowledge in this field to a worldwide audience, and accordingly, its editorial board has an international membership.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
